Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Breast Diseases
Interventions: DRUG: Anastrozole|DRUG: Palbociclib|DRUG: Trastuzumab|DRUG: Pertuzumab
Sponsor: Icahn School of Medicine at Mount Sinai
Collaborators: Herbert Irving Comprehensive Cancer Center|Weill Medical College of Cornell University|NYU Langone Health